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Abstract
The survival of bacteria in nature is greatly enhanced by their ability to grow within surface-associated communities called
biofilms. Commonly, biofilms generate proliferations of bacterial cells, called microcolonies, which are highly recalcitrant, 3-
dimensional foci of bacterial growth. Microcolony growth is initiated by only a subpopulation of bacteria within biofilms,
but processes responsible for this differentiation remain poorly understood. Under conditions of crowding and intense
competition between bacteria within biofilms, microevolutionary processes such as mutation selection may be important
for growth; however their influence on microcolony-based biofilm growth and architecture have not previously been
explored. To study mutation in-situ within biofilms, we transformed Pseudomonas aeruginosa cells with a green fluorescent
protein gene containing a +1 frameshift mutation. Transformed P. aeruginosa cells were non-fluorescent until a mutation
causing reversion to the wildtype sequence occurs. Fluorescence-inducing mutations were observed in microcolony
structures, but not in other biofilm cells, or in planktonic cultures of P. aeruginosa cells. Thus microcolonies may represent
important foci for mutation and evolution within biofilms. We calculated that microcolony-specific increases in mutation
frequency were at least 100-fold compared with planktonically grown cultures. We also observed that mutator phenotypes
can enhance microcolony-based growth of P. aeruginosa cells. For P. aeruginosa strains defective in DNA fidelity and error
repair, we found that microcolony initiation and growth was enhanced with increased mutation frequency of the organism.
We suggest that microcolony-based growth can involve mutation and subsequent selection of mutants better adapted to
grow on surfaces within crowded-cell environments. This model for biofilm growth is analogous to mutation selection that
occurs during neoplastic progression and tumor development, and may help to explain why structural and genetic
heterogeneity are characteristic features of bacterial biofilm populations.
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Introduction
Autonomously replicating cells under conditions of cellular
crowding, for example within eukaryotic malignancies, are
constrained by intensely competitive and nutrient limited growth
conditions. In these circumstances microevolutionary processes,
such as mutation selection, are often important for growth. For
example, central to the development of many tumors is
destabilization of the genome and establishment of a mutator
phenotype [1,2]; mutants selected for their ability to proliferate,
while surviving environmental stresses, expand their numbers and
contribute to tumor growth and progression.
Bacteria often face similar constraints for growth in crowded cell
populations. They largely exist within matrix-encased and densely
packed communities of cells called biofilms. In biofilms, bacteria
develop discrete foci of proliferation, called microcolonies, which
become markedly differentiated from the surrounding biofilm.
Microcolonies are typically tolerant to most antimicrobial
compounds and play an important role in many persistent biofilm
infections [3–6]. Importantly, cells within microcolonies often
proliferate rapidly while other biofilm bacteria are non-dividing
and do not increase their biovolume [7]. Studies indicate that
early-stage microcolonies of this kind are clonal structures derived
from a single cell within the biofilm [8,9].
Intriguingly, bacteria in biofilms commonly exhibit mutator
phenotypes [10,11] and phenotypic variation [12–16], suggesting
that mutation and genetic destabilization are an important
feature of biofilm development. Factors influencing the evolution
of high mutation rates in bacterial populations are a topic of
much recent interest [17–20], and several recent studies have
identified a role for oxidative stress in generating mutation and
phenotypic variation among biofilm bacteria [21–23]. However
the possibility of a role for mutation and genetic change in
determining biofilm architecture and microcolony-based growth
has not previously been explored and does not feature currently
among empirical or mathematical models for biofilm develop-
ment [7,24–27]. To investigate these potential influences we have
examined the role of mutation and mutator phenotypes on
microcolony initiation in Pseudomonas aeruginosa biofilms. We also
designed an experimental procedure using a mutated GFP gene
containing a frameshift mutation that results in a loss of GFP
expression. This allows real-time observation of fluorescence
inducing reversion mutations (FIMS) in-situ within biofilms
formed by P. aeruginosa.
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GFP-based mutation detection
A GFP-based mutation detection plasmid (pMDGFP) was
constructed to allow visualization of P. aeruginosa cells that undergo
frameshift mutation events in P. aeruginosa biofilms. To test the
reversion plasmid, P. aeruginosa containing plasmid pMDGFP was
grown in planktonic batch cultures treated with 0, 8 or 16 mgm l
21
of ICR-191, an acridine mutagen that induces predominantly +1
and 21 frameshifts in runs of three or more monotonic GC base
pairs [28]. Following overnight incubation with the mutagen,
planktonic cells were plated on agar and fluorescent colonies
enumerated. The number of fluorescent colonies observed at each
dose level is shown in Table 1. We did not detect any FIMS in
untreated planktonic cultures that were not exposed to the
chemical mutagen ICR-191. We examined approximately
1.45610
6 CFU formed by untreated bacteria plated onto agar
and did not observe any fluorescent colonies. However, the mutant
fractions for P. aeruginosa cultures treated with 8 and 16 mgm l
21
ICR-191 were 2.023.6610
25 and 6.7210.0610
25 respectively.
Our data agree closely with previously published work that has
assessed the mutagenicity of ICR-191 using plasmid-based
reversion systems in E. coli [29,30].
Mutation detection in P. aeruginosa pMDGFP biofilms
Although we did not observe FIMS in unmutagenized
planktonic cultures, we frequently observed FIMS during biofilm
culture of P. aeruginosa cells containing the pMDGFP plasmid. We
observed that fluorescent cells were localized within microcolony
structures within the biofilm; in contrast, cells within non-
microcolony regions of the biofilm did not contain FIMS in our
experiments (Figure 1). Microcolonies contained single fluorescent
cells (Figure 1A) or clusters of fluorescent cells (Figure 1B, C).
Occasionally, whole microcolonies were observed to be fluores-
cent, adjacent to microcolonies of similar size and density that
were non-fluorescent (Figure 1D), indicating that FIMS had
occurred at an early stage during the clonal development of the
microcolony. The GFP+1 construct was also delivered to the P.
aeruginosa chromosome using a mini-Tn7 insertion cassette and
delivery vector pMDGFPTn7. Unlike pMDGFP, we were unable
to detect brightly fluorescent cells within biofilms when the GFP+1
gene was inserted into the P. aeruginosa chromosome in this way.
This may be because the single copy chromosomal GFP+1 gene
did not result in sufficiently bright fluorescence in the event of a +1
frameshift mutation – thus it is possible that single copy GFP
systems are not sensitive enough to detect FIMS in our biofilm
system. However, we carried out RNA extraction from 10-day old
biofilms and semi-quantitative reverse transcriptase PCR analysis
showed that in-frame GFP mRNA was present in the biofilm, but
was absent from planktonic cells incubated for the same period in
shaking culture (data not shown). We therefore suggest that the
GFP+1 chromosomal insertion from pMDGFPTn7 had acquired
frameshift mutations within the biofilm, but that insufficient fully
folded fluorescent protein was produced to enable fluorescent
microscopic observation.
We observed a mean of 1.5160.25 FIMS mm
22 within P.
aeruginosa pMDGFP biofilms on the glass substratum. Flow cell
channels containing WTP. aeruginosa biofilms, and channels that were
inoculated with suspensions of 1610
9 CFU ml
21 planktonic
pMDGFP P. aeruginosa, were also examined and we did not observe
FIMS in these control experiments. The mean biovolume of P.
aeruginosa biofilms at 7 days was 1.8860.27610
6 mm
3 mm
22,
containing an estimated 1.4610
4 –1.1610
5 viable cells [31]. The
frequency of reversion mutations in biofilms was therefore
1.3610
2562.2610
26–1.1610
2461.8610
25, indicating a minimum
increase in mutation frequency of between 6 and 100-fold within the
biofilm compared with planktonic cells in our agar plate based assay
for mutation detection. However, mutations were observed only
within microcolonies, which at 7 days represented 6.261.1% of the
total biovolume within our biofilms. Therefore microcolony-specific
increases in mutation frequency were at least 100-fold in our
experiments,and may be up to 1800 foldhigher than that observed in
planktonic culture. In summary, our data show that bacteria within
microcolonies, but not other biofilm bacteria, exhibit elevated
frequencies of frameshift mutations within P. aeruginosa biofilms.
Role of mutator phenotypes in microcolony-based
biofilm growth
Because mutation frequencies were enhanced in P. aeruginosa
biofilm microcolonies, we examined in more detail whether
mutation can influence microcolony growth and development. To
determine whether mutation can play a role in microcolony
initiation, biofilm growth of P. aeruginosa PAO1 WT, DmutS, DmutL
and complemented mutant strains were compared using confocal
scanning laser microscopy (Figures 2 and 3). PAO1 DmutS cells are
unable to repair DNA mismatch errors and exhibit a mutator
phenotype with mutation frequencies typically 100 times greater
than WT cells, based on a ciprofloxacin resistance assay [32]. We
also observed an approximate 100 fold increase in rifampicin
resistance mutation frequency in our experiments using the DmutS
strain, as well as for the DmutL strain constructed in our laboratory,
and were able to restore the mutation frequency to wild-type levels
by complementation of each of these genes (data not shown). The
PAO1 DmutS and DmutL strains both formed biofilms with
significantly enhanced microcolony growth compared to both
the wild-type and respective complemented strains. Biofilms
created by the hypermutator strains were significantly larger in
total biovolume and maximum microcolony thickness (Figure 2,
P,0.05). Thus, mutations in genes that lead to mutator
phenotypes in P. aeruginosa can enhance microcolony initiation
and growth during biofilm culture.
Discussion
Numerous biomedical and environmental biotechnological
applications are affected by the ability of bacteria to grow and
Table 1. Influence of mutagen dose levels on mutation rate
in P. aeruginosa assessed by pMDGFP FIM fluorescent colony
assays.
ICR-191 mgm l
21
Cells/plate
( 610
5 )
Fluorescent
CFU/plate Mutant fraction
0 1.1 0 ,1.45610
26
5.3 0
7.8 0
8 1.1 4 3.6610
25
1.9 4 2.1610
25
4.6 9 2.0610
25
16 1.1 11 1.0610
24
2.2 16 7.3610
25
2.7 18 6.7610
25
Data for each of three replicate experiments are shown.
doi:10.1371/journal.pone.0006289.t001
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advances in understanding genetic determinants involved in
biofilm formation, the growth and development of discrete 3-
dimensional microcolony structures within bacterial biofilm
communities remains poorly understood. Here we show that
microevolutionary processes are involved in the structural
development of bacterial biofilms. The work presented here is
the first to link mutation with the microcolony architecture of
biofilms, and shows that i) bacteria within microcolonies exhibit
enhanced mutation frequencies compared with other biofilm
bacteria, and ii) bacteria with an elevated mutation frequency can
exhibit enhanced microcolony development.
In our experiments, we used a GFP reversion system to detect -1
frameshift mutations in-situ within biofilms. Mutations that led to
GFP fluorescence occurred specifically within microcolony
structures. This observation may suggest that microcolonies, as
distinct from non-microcolony biofilm bacteria, may play an
important role as foci for genetic adaptation and evolution. For
example, strains of bacteria with high mutation frequencies can
acquire resistance to antibiotics more rapidly than wild-type strains
[33,34], and also can exhibit enhanced horizontal acquisition of
exogenous DNA [35]. Microcolonies may therefore represent key
sites of rapid genetic adaptation to antibiotic therapy or other
environmental stresses compared with other biofilm bacteria.
Documented processes of bacterial dispersal from the interior
portions of microcolonies would also provide a mechanism by
which new genetic variant cells could be released from the biofilm
and colonize new environments [36–39]. Moreover, long-term
infection of the airways of cystic fibrosis patients by Pseudomonas
aeruginosa is associated with a series of mutations and specific
genetic adaptations to the airway environment [40]. Our data
points to microcolony structures as specific sites within biofilms for
enhanced genetic adaptation and evolutionary change during
chronic respiratory infections such as those associated with cystic
fibrosis.
Several possibilities may explain why mutations within biofilms
were localized within microcolonies. Microcolonies are foci of cell
division and growth within biofilms [7]. Because DNA replication
occurs predominantly in dividing cells, microcolonies undergoing
DNA replication may accumulate mistakes in DNA replication
more rapidly than non-proliferating bacteria. This could lead to
the increase in FIMS observed within microcolony structures
(Figure 1). However, we did not observe FIMs in rapidly growing
planktonic cultures, therefore enhanced DNA replication and cell
division in microcolonies cannot alone account for our observa-
tions of microcolony-specific mutational events. Mutation could
also be a consequence of locally induced DNA-damaging stresses
within microcolonies. There are many sources of endogenous
DNA damage that can cause mutation within cells, including toxic
oxidative products of normal metabolism [41,42]. Microcolonies
generate steep gradients in oxygen and nutrients, which may
rapidly generate stresses caused by the accumulation of metabo-
lites. Indeed, several studies have detected endogenous production
of reactive oxygen and nitrogen intermediates localized within
biofilm microcolonies [43,44], and oxidative stress has previously
been linked to the occurrence of hypermutable P. aeruginosa strains
in cystic fibrosis infection [45]. Thus it is possible that the unique
environment induced by microcolony growth per se may alter
Figure 1. GFP fluorescence-inducing mutations (FIMS) occur during P. aeruginosa pMDGFP biofilm development. FIMS were observed
exclusively within microcolony structures, but not within unstructured ‘carpet’ regions of the biofilm as in (A), which shows bright field (BF) and
fluorescence (FL) images of the same field of view. FIMS were observed as individual GFP-expressing cells (A), or as clusters of GFP cells within
microcolonies possibly due to clonal expansion following GPF reversion (B, C). Microcolonies comprised wholly of GFP-expressing cells were
occasionally observed (D).
doi:10.1371/journal.pone.0006289.g001
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population.
An important question is whether mutation in biofilms may also
be a direct cause of microcolony growth. Our data suggest that
mutator phenotypes in biofilms can promote microcolony
initiation. Experiments involving P. aeruginosa DmutS and DmutL
strains show that enhanced mutation frequencies in P. aeruginosa
can promote microcolony growth within biofilms (Figures 2 and 3).
Figure 2. P. aeruginosa DmutS and DmutL strains exhibit enhanced microcolony initiation and development (A), and also show
increased total biofilm volume (B) and maximum microcolony thickness (C). Biofilm development of P. aeruginosa PAO1 WT, DmutS,
DmutL, DmutS+pUCPMS and DmutL+pUCmutL grown in continuous culture flow cells over a 10 day period and examined using confocal scanning
laser microscopy. Asterisks indicate a significant difference compared with WT or related complemented strain (P,0.05).
doi:10.1371/journal.pone.0006289.g002
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PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6289Figure 3. Representative confocal scanning laser microscopy images showing biofilms of P. aeruginosa wild-type, DmutS, DmutL and
complemented strains after 10 days of biofilm development. The central images show a top-down view of the biofilm; side panels are
vertical sections. Scale bar represents 150 mm.
doi:10.1371/journal.pone.0006289.g003
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mutation selection, analogous to commonly held models for tumor
development (Figure 4). Thus mutated bacterial cells selected for
their ability to proliferate on surfaces can expand in number and
develop microcolony structures within biofilms. Eukaryotic tumors
contain many clonal mutations, i.e. mutations that are present in a
proportion of tumor cells and on which selection occurs because
they confer a growth advantage. Neoplasms therefore, are
composed of ecosystems of evolving clones [46], each competing
with other cells in their microenvironment. Within microcolony
structures, most of the dynamics of clones and their evolution have
not been studied, including mutation rates, fitness effects of
mutations within colonies, and competition between co-evolving
clones. From the perspective of tumor biology, the capacity to
manipulate bacteria to study such processes – particularly the
ability to rapidly modify and assess genetic mechanisms – may
exceed the analogous capacity in mammalian tumor cells. Thus
extension of this work may point the way to a more comprehensive
understanding of evolutionary aspects of bacterial biofilm
development, as well as providing new perspectives with which
to study tumor progression.
Materials and Methods
Bacterial strains, plasmids and culture media
P. aeruginosa strain PAO1, and two PAO1 mutant strains, DmutS
and DmutL, were used in this study [32,47,48]. Complementing
plasmids, pUCPMS [32] and pUCmutL (this study), containing
mutS and mutL respectively were used to restore a wildtype
phenotype. The mutL region of PAO1 was amplified using MutLF,
59-CGCGGTAGATCAGCGCCGAGTCGAC-39; and MutLR,
59-CCAGGGCAAGCTCTCCATGGGGCC -39 with Phusion-
Flash Mastermix (FinnzymesOy, Finland). The purified 2.3Kbp
blunt ended fragment was cloned into the SmaI site of pUC24 [49]
to create pUCmutL. Transformants were selected from LB agar
plates containing 30 mgm l
21 gentamicin. The insert orientation
was confirmed by PCR using M13 forward primer combined with
MutLR primer, and complementation of PAO1DmutL phenotype
shown using the rifampicin resistance method. Batch cultures of P.
aeruginosa were grown at 37uC with shaking (230 rpm) in Luria-
Bertani (LB) broth (Foremedium, UK). Biofilms were cultured
using a modified Luria-Bertani broth containing tryptone
1.0 g L
21, yeast extract 0.5 g L
21, NaCl 10.0 g L
21. Spontane-
ous rifampicin resistance assays were performed using Mueller-
Hinton broth and agar (Sigma Aldrich, UK).
Plasmids pMF230 and AKN66 were kindly provided by
Michael Franklin, Centre for Biofilm Engineering, Bozeman,
MT [50] and Soren Molin, Denmark Technical University [51]
respectively. Plasmid pUCPMS was maintained during batch
culture and biofilm experiments by the addition of 50 mgm l
21
gentamicin; pMDGFP was maintained in E. coli and P. aeruginosa
cultures by the addition of 50 mgm l
21 ampicillin and 400 mgm l
21
carbenicillin, respectively.
Mutation detection assay – vector construction and
validation
The GFP reversion method has previously been developed for
assays of frameshift mutation in eukaryotic and bacterial cells
[29,52]. A +1 frameshift mutation was created within the GFP
encoding region of pMF230 and AKN66 using the Phusion
TM
site-directed mutagenesis kit (FinnzymesOy). Plasmid pMF230 is a
high copy number plasmid whereas AKN66 is a mini-Tn7 delivery
transposon vector that inserts a single copy of a desired genetic
sequence into P. aeruginosa [51]. Briefly, mutagenic primers
originating within the GFPmut2 sequence amplified pMF230 and
AKN66 and introduced one additional cytosine residue following
a native CCC sequence (GFPmut2 Genbank accession number
AF302837, bp 337-339). The primers used were GFP+1F, 59-
CGT GCT GAA GTC AAG TTT GAA GGT GA-39, and
GFP+1R, 59-TGT CTT GTA GTT CCC CGT CAT CTT T-39,
with the inserted cytosine residue underlined. This produced
double stranded linear products that were recircularized by
ligation to form plasmids pMDGFP and pMDGFPTn7 and
transformed into 5-alpha competent E. coli (New England Biolabs,
UK). Transformants were selected on LB medium containing
50 mgm l
21 ampicillin and a single non-fluorescent colony was
selected for DNA sequencing of the GFPmut2 gene to confirm the
presence of the +1 frameshift within pMDGFP. Cells from an
overnight culture of P. aeruginosa PAO1 were recovered by
centrifugation and mixed with 50 ng of purified pMDGFP
(Qiagen Plasmid Prep Kit). The cell and DNA mix were
suspended in a 300 mM sucrose solution, transformed by
electroporation [53], and plated onto LB agar containing
400 mgm l
21 carbenicillin. Use of a GFP plasmid-based mutation
detection system may enhance the sensitivity of mutation detection
due to i) multiple copies of the frameshift-containing GFP gene;
pMF230-based plasmids have a copy number of approximately
50–100 per P. aeruginosa cell (M. Franklin, unpublished), and ii)
presence of a CCCC sequence within the mutated GFP gene;
polycytosine repeats can increase sensitivity to frameshift muta-
tions [28].
The chemical mutagen ICR-191 (CAS No. 17070-45-0), Sigma
(Poole, UK), was dissolved in DMSO at a concentration of
5m gm l
21. Ten ml of an overnight bacterial culture of P.
aeruginosa-pMDGFP were inoculated into 10 ml of LB broth in a
50 ml polypropylene tube containing the appropriate amount of
mutagen. The culture was grown at 37uC for 18 h in a light-
protected shaking incubator (230 rpm). Bacteria were then pelleted
by centrifugation, resuspended in 10 ml fresh LB, and incubated
for an additional 6 h. A serial dilution of the cells was plated onto
LB medium and incubated at 37uC for approximately 16 h.
Figure 4. Microevolutionary model for microbial biofilm
growth. (A) A bacterial cell attached to a substratum acquires a
primary mutation ($) that provides a growth advantage on the surface;
(B) mutation selection and clonal expansion occurs; some cells acquire
beneficial secondary mutations (), for example due to exogenous DNA
damaging stresses localized to microcolonies; (C) subsequent waves of
clonal expansion contribute to microcolony growth and proliferation.
doi:10.1371/journal.pone.0006289.g004
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approximately 1610
5 CFU were examined for mutational events
leading to GFP fluorescence using epifluorescence microscopy and
a4 6objective lens.
Fluorescent colonies induced by ICR-191could be re-streaked
to obtain individual isolated fluorescent colonies containing stable
revertant GFP-expressing plasmids. By isolating and sequencing
plasmid DNA from green fluorescent cells, previous studies using
GFP-based reversion detection systems have shown that reversion
and GFP production by a relatively small fraction of the total
plasmids is sufficient for fluorescence [29].
Biofilm experiments
P. aeruginosa pMDGFP biofilms were grown in continuous-
culture flow cells [54] (channel dimensions, 164640 mm; flow
rate, 150 ml min
-1) at room temperature. Each channel was
inoculated with 1.0 ml of overnight P. aeruginosa culture and
incubated for 1 h at room temperature without flow to allow for
bacterial attachment to the glass substratum. In order to ensure
that an equal density of attached bacterial cells were used to
initiate biofilm formation we compared WT and DmutS strains in
our glass flow cell system. After a 2 hr adhesion period, cells were
enumerated and no significant difference in attachment was found
(data not shown). The flow of culture medium was then started
and biofilm growth and development was monitored daily under
bright field microscopy. Biofilms were observed at various
timepoints when prominent, established microcolonies were
visible. Epifluorescence microscopic examination of GFP fluores-
cence was carried out using an Olympus BX61 microscope
equipped with a GFP filter set (BP460-480 nm/BA495-540 nm,
Olympus) and captured using a digital camera (Infinity2-2C,
http://www.lumenera.com). The intensity of GFP fluorescence
observed within P. aeruginosa cells was highly variable with camera
exposure times ranging from 5 ms to 45 ms.
Biofilm Quantitation
Confocal laser scanning images of 7 and 10-day old continuous
culture biofilms were obtained using a Leica (TCS SP2 MP FCS)
upright microscope and 206/0.70 objective. Images were
102461024-pixel resolution and used identical gain, offset and
pinhole settings for each data collection point. To enable
visualization of cells within the biofilm the medium supply to the
flowcell was stopped and each channel was stained for 30 min with
1.0 ml DNA staining solution (5 mM SYTO-9 in LB-10; Invitrogen,
U.K.), followed by a period of 10 min with medium flow to wash
out excess stain. A single argon laser line was used with excitation
wavelength of 488 nm and using an emission filter with a bandpass
of 500–600 nm. Three-dimensional rendering and analysis was
performed using COMSTAT software [55] on the Matlab
platform. COMSTAT analyzed each stack for the total number
and volume of microcolonies (.300 pixels) at the substratum (mm
3),
and total biomass (mm
3). For each image stack, total microcolony
volume was expressed as percentage of total biofilm biovolume.
Values are calculated means of data from 20 image stacks (5 image
stacks from two different channels in two separate experiments).
Bacterial cell numbers within biofilms were calculated based on a
cell density of 7.5610
9–6.0610
10 CFU ml
21 which was previously
determined using individual microcolonies that were measured
(volume) and then removed from P. aeruginosa biofilms by
micropipette [31]; and P. Stoodley, personal communication).
Mutation frequency assay by activation of the rifampicin
resistance gene
Mutation frequencies of all the strains used were estimated using
the spontaneous rifampicin resistance method [10]. Briefly,
individual 20 ml overnight Mueller-Hinton (MH) broth cultures
of each of the P. aeruginosa strains were plated onto MH agar plates
with and without rifampicin (300 mgm l
21) for enumeration
following incubation at 37uC for approximately 36 h. All strains
were previously susceptible to such concentrations of rifampicin.
All experiments were repeated in triplicate and the relevant
frequency means calculated.
Statistical analyses
Statistical analyses of biofilm data from COMSTAT were
performed using the Student’s t-test and one-way analyses of
variance (ANOVA). A significant difference was considered to be
p,0.05.
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